Evidence map›Paper›PMID 36513776›Full record

ArticleScientific reports2022

Bioengineered synthesis of phytochemical-adorned green silver oxide (Ag

Maryam Shahzad Shirazi, Mahdi Moridi Farimani, Alireza Foroumadi, Kamal Ghanemi, Maurizio Benaglia, Pooyan Makvandi

Abstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Hydrothermal synthesis of FeRSC advances · 2025
    Article
  3. Article
  4. Green Synthesis of Silver Oxide Nanoparticles fromNanomaterials (Basel, Switzerland) · 2024
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Antibacterial and Antibiofilm Activity ofMolecules (Basel, Switzerland) · 2023
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Maryam Shahzad ShiraziDepartment of Phytochemistry, Medicinal Plants and Drugs Research Institute, Shahid Beheshti University, Tehran, Iran.
Mahdi Moridi FarimaniDepartment of Phytochemistry, Medicinal Plants and Drugs Research Institute, Shahid Beheshti University, Tehran, Iran. m_moridi@sbu.ac.ir.ORCID 0000-0001-9273-1019
Alireza ForoumadiDepartment of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Kamal GhanemiDepartment of Marine Chemistry, Faculty of Marine Science, Khorramshahr University of Marine Science and Technology, Khorramshahr, Iran.
Maurizio BenagliaDipartimento di Chimica, Università degli Studi di Milano, Via Golgi, 19, 20133, Milan, Italy.
Pooyan MakvandiCentre for Materials Interfaces, Istituto Italiano di Tecnologia, viale Rinaldo Piaggio 34, 56025, Pontedera, Pisa, Italy. pooyanmakvandi@gmail.com.ORCID 0000-0003-2456-0961

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Silver oxide nanoparticles have various biomedical and pharmaceutical applications. However, conventional nanofabrication of Ag

Indexed as

FicusMentha pulegiumMetal NanoparticlesAnti-Bacterial AgentsAntifungal AgentsAntioxidantsEscherichia coliFlavonoidsOxidesPhenolsPhytochemicalsPlant ExtractsSilver CompoundsSpectroscopy, Fourier Transform InfraredAnti-Bacterial AgentsAntifungal AgentsAntioxidantsdisilver oxideFlavonoidsOxidesPhenolsPhytochemicalsPlant ExtractsSilver Compounds

Identifiers

PMID36513776
PMCPMC9748139

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.